Enzo Biochem完成向Labcorp出售临床实验室后,股价上涨23%。来自ChatGPT翻译。查看全文
恩佐生化(ENZ)03-14 04:35
$恩佐生化(ENZ)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-022179 Act: 34 Size: 5 MB 网页链接查看全文
恩佐生化(ENZ)03-14 04:35
$恩佐生化(ENZ)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-022188 Act: 34 Size: 326 KB 网页链接查看全文
恩佐生化(ENZ)02-28 05:15
$恩佐生化(ENZ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-017523 Size: 5 KB 网页链接查看全文
恩佐生化(ENZ)02-28 05:15
$恩佐生化(ENZ)$ 8-K Current report, item 5.02 Accession Number: 0001213900-24-017519 Act: 34 Size: 194 KB 网页链接查看全文
恩佐生化(ENZ)02-28 08:25
$恩佐生化(ENZ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-017640 Size: 9 KB 网页链接查看全文
恩佐生化(ENZ)02-14 23:25
$恩佐生化(ENZ)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023141 Act: 34 Size: 56 KB 网页链接查看全文
恩佐生化(ENZ)02-13 22:45
$恩佐生化(ENZ)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001037389-24-000010 Act: 34 Size: 13 KB 网页链接查看全文
恩佐生化(ENZ)02-01 21:35
$恩佐生化(ENZ)$ 8-K Current report, items 5.02, 5.07, 7.01, and 9.01 Accession Number: 0001213900-24-008745 Act: 34 Size: 235 KB 网页链接查看全文
不入流资讯2023-07-25 17:19
$恩佐生化(ENZ)$ Enzo Biochem jumps 23% after completing sale of clinical laboratory to Labcorp
Enzo Biochem完成向Labcorp出售临床实验室后,股价上涨23%。来自ChatGPT翻译。查看全文
牛唐2021-03-21 15:41
$恩佐生化(ENZ)$ 在公布四季度财报后,CEO Dr. Rabbani提出辞呈,该行为受到大股东Harbert Discovery Fund的欢迎,但公司董事会未批准Dr. Rabbani的辞职。$钱江生化(SH600796)$ $绿康生化(SZ002868)$查看全文
美股短线交易员2020-03-12 11:03
$恩佐生化(ENZ)$ Trump speak on TV that " Testing is expanding rapidly day by day"查看全文
马虎公路2020-03-12 02:46
$风云际会(ZH2071612)$ @桂圆那个桂圆 调出$恩佐生化(ENZ)$ 之后,防疫类股票只剩一只$热生物制剂(HTBX)$ ,仓位8%,组合无法买卖,记录一下。防疫类的可能就做到这里了吧,后面先把精力放在指数正相关的版块上了。航空股,起飞吧查看全文
智通财经APP预告,2021年10月12日,港美股上市公司活动及香港重要财经会议信息情况如下: 20:30恩佐生化(ENZ.US) 恩佐生化(ENZ.US)2021年第四季度业绩电话会网络转播22:00快扣(FAST.US) 快扣(FAST.US)2021年第三季度业绩电话会网络转播2... 网页链接
智通财经APP预告,2021年3月16日,港美股上市公司活动及香港重要财经会议信息情况如下: 04:00 Startek, Inc.(SRT.US) Startek, Inc.(SRT.US)2020年第四季度业绩电话会 网络转播 04:30 恩佐生化(ENZ.US) 恩佐生化(ENZ.US)2020年第四季度... 网页链接
$恩佐生化(ENZ)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001037389-19-000037 Size: 13 KB 网页链接
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2019-02-11 AccNo: 0000930413-19-000395 Size: 205 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$恩佐生化(ENZ)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-11 AccNo: 0001144204-19-006191 Size: 63 KB 网页链接
$恩佐生化(ENZ)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-04 AccNo: 0000215457-19-004069 Size: 13 KB 网页链接
$恩佐生化(ENZ)$ 内部交易: 2019-01-14,Pres, CFO Prin Acct Ofcr Treas,WEINER BARRY W ,期权,2226普通股, $2.70
$恩佐生化(ENZ)$ 内部交易: 2019-01-14,Director,BORTZ GREGORY M. ,期权,9184普通股, $2.70
$恩佐生化(ENZ)$ 内部交易: 2019-01-14,Director,Perlysky Dov ,期权,9184普通股, $2.70
$恩佐生化(ENZ)$ 内部交易: 2019-01-14,Chm of the Bd, CEO and Sec,RABBANI ELAZAR ,期权,2782普通股, $2.70
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2019-01-03 AccNo: 0000930413-19-000010 Size: 22 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of M...
$恩佐生化(ENZ)$ 8-K - Current report Filed: 2018-12-10 AccNo: 0000930413-18-003527 Size: 91 KBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接